Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 17/20 | 0.62 |
| ▸ | IL23R | Q5VWK5 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29982283 | 1.00 | KISS1R (0.62) | KISS1RIL23R | |
| SCHEMBL30401759 | 0.98 | KISS1R (0.61) | KISS1RIL23R | |
| SCHEMBL29981946 | 0.98 | KISS1R (0.59) | KISS1RIL23R | |
| SCHEMBL29981974 | 0.98 | KISS1R (0.59) | KISS1RIL23R | |
| SCHEMBL29981789 | 0.91 | IL23R (0.58) | KISS1RIL23R | |
| SCHEMBL29982442 | 0.90 | KISS1R (0.54) | KISS1RIL23R | |
| SCHEMBL29982290 | 0.90 | KISS1R (0.54) | KISS1RIL23R | |
| SCHEMBL30093011 | 0.89 | IL23R (0.54) | KISS1RIL23R | |
| SCHEMBL31257886 | 0.89 | CCKAR (0.60) | KISS1R | |
| SCHEMBL30339295 | 0.89 | CCKBR (0.62) | IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240366775-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING ANTIBODY-PEPTIDE CONJUGATE | PEPTIDREAM INC. (JP) | 2024-11-07 | — | — | US | claimed |
| EP-4393959-A1 | HUMAN TRANSFERRIN RECEPTOR-BINDING ANTIBODY-PEPTIDE CONJUGATE | PeptiDream Inc. (JP) | 2024-07-03 | — | — | EP | claimed |
| WO-2023027125-A1 | HUMAN TRANSFERRIN RECEPTOR-BINDING ANTIBODY-PEPTIDE CONJUGATE | ペプチドリーム株式会社 | 2023-03-02 | — | — | WO | claimed |
| US-20240366775-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING ANTIBODY-PEPTIDE CONJUGATE | PEPTIDREAM INC. (JP) | 2024-11-07 | — | — | US | disclosed |
| US-20240366775-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING ANTIBODY-PEPTIDE CONJUGATE | PEPTIDREAM INC. (JP) | 2024-11-07 | — | — | US | disclosed |
| EP-4393959-A1 | HUMAN TRANSFERRIN RECEPTOR-BINDING ANTIBODY-PEPTIDE CONJUGATE | PeptiDream Inc. (JP) | 2024-07-03 | — | — | EP | disclosed |
| EP-4393959-A1 | HUMAN TRANSFERRIN RECEPTOR-BINDING ANTIBODY-PEPTIDE CONJUGATE | PeptiDream Inc. (JP) | 2024-07-03 | — | — | EP | disclosed |
| WO-2023027125-A1 | HUMAN TRANSFERRIN RECEPTOR-BINDING ANTIBODY-PEPTIDE CONJUGATE | ペプチドリーム株式会社 | 2023-03-02 | — | — | WO | disclosed |
| WO-2023027125-A1 | HUMAN TRANSFERRIN RECEPTOR-BINDING ANTIBODY-PEPTIDE CONJUGATE | ペプチドリーム株式会社 | 2023-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240366775-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING ANTIBODY-PEPTIDE CONJUGATE | TFRC, MET, SLC7A1 | KISS1R 1979/4885IL23R 517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.